Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SCRG1 mRNA | CTD | PMID:32109520 | 3-chloropropane-1,2-diol | increases expression | EXP | | 6480464 | alpha-Chlorohydrin results in increased expression of SCRG1 mRNA | CTD | PMID:28522335 | 4,4'-sulfonyldiphenol | increases expression | ISO | SCRG1 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of SCRG1 mRNA | CTD | PMID:33476716 | 4,4'-sulfonyldiphenol | decreases expression | ISO | Scrg1 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of SCRG1 mRNA | CTD | PMID:34850234 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of SCRG1 mRNA | CTD | PMID:24780913 | 8-Br-cAMP | increases expression | ISO | SCRG1 (Homo sapiens) | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SCRG1 mRNA | CTD | PMID:22079614 | aflatoxin B1 | decreases methylation | ISO | SCRG1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of SCRG1 intron | CTD | PMID:30157460 | alachlor | affects expression | EXP | | 6480464 | alachlor affects the expression of SCRG1 mRNA | CTD | PMID:19425180 | all-trans-retinoic acid | decreases expression | ISO | SCRG1 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of SCRG1 mRNA | CTD | PMID:21934132 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of SCRG1 mRNA | CTD | PMID:16483693 | arsane | multiple interactions | ISO | SCRG1 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SCRG1 mRNA | CTD | PMID:32525701 | arsenic atom | multiple interactions | ISO | SCRG1 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SCRG1 mRNA | CTD | PMID:32525701 | atrazine | increases expression | ISO | SCRG1 (Homo sapiens) | 6480464 | Atrazine results in increased expression of SCRG1 mRNA | CTD | PMID:22378314 | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of SCRG1 mRNA | CTD | PMID:29945229 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SCRG1 mRNA | CTD | PMID:25181051 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of SCRG1 gene | CTD | PMID:28505145 | bisphenol A | decreases expression | ISO | SCRG1 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of SCRG1 mRNA | CTD | PMID:27685785 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of SCRG1 promoter | CTD | PMID:22457795 | carbamazepine | affects expression | ISO | SCRG1 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of SCRG1 mRNA | CTD | PMID:25979313 | carbon nanotube | increases expression | ISO | Scrg1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | clobetasol | increases expression | ISO | Scrg1 (Mus musculus) | 6480464 | Clobetasol results in increased expression of SCRG1 mRNA | CTD | PMID:27462272 | clofibrate | increases expression | ISO | Scrg1 (Mus musculus) | 6480464 | Clofibrate results in increased expression of SCRG1 mRNA | CTD | PMID:17585979 | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of SCRG1 mRNA | CTD | PMID:26577399 and PMID:27523638 | dorsomorphin | multiple interactions | ISO | SCRG1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | elemental selenium | decreases expression | ISO | SCRG1 (Homo sapiens) | 6480464 | Selenium results in decreased expression of SCRG1 mRNA | CTD | PMID:19244175 | ethanol | increases expression | ISO | Scrg1 (Mus musculus) | 6480464 | Ethanol results in increased expression of SCRG1 mRNA | CTD | PMID:30319688 | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of SCRG1 gene | CTD | PMID:22079235 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of SCRG1 mRNA | CTD | PMID:22061828 | indometacin | increases expression | ISO | SCRG1 (Homo sapiens) | 6480464 | Indomethacin results in increased expression of SCRG1 mRNA | CTD | PMID:17401462 | leflunomide | increases expression | ISO | Scrg1 (Mus musculus) | 6480464 | leflunomide results in increased expression of SCRG1 mRNA | CTD | PMID:19751817 | lipopolysaccharide | multiple interactions | ISO | SCRG1 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SCRG1 mRNA | CTD | PMID:35811015 | methamphetamine | decreases expression | EXP | | 6480464 | Methamphetamine results in decreased expression of SCRG1 mRNA | CTD | PMID:28619521 | Muraglitazar | decreases expression | EXP | | 6480464 | muraglitazar results in decreased expression of SCRG1 mRNA | CTD | PMID:21515302 | nickel atom | decreases expression | ISO | SCRG1 (Homo sapiens) | 6480464 | Nickel results in decreased expression of SCRG1 mRNA | CTD | PMID:24768652 and PMID:25583101 | ozone | multiple interactions | ISO | Scrg1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SCRG1 mRNA | CTD | PMID:27106289 | panobinostat | multiple interactions | ISO | SCRG1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCRG1 mRNA | CTD | PMID:27188386 | panobinostat | increases expression | ISO | SCRG1 (Homo sapiens) | 6480464 | panobinostat results in increased expression of SCRG1 mRNA | CTD | PMID:26272509 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | SCRG1 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SCRG1 mRNA | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | SCRG1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | selenium atom | decreases expression | ISO | SCRG1 (Homo sapiens) | 6480464 | Selenium results in decreased expression of SCRG1 mRNA | CTD | PMID:19244175 | silicon dioxide | decreases expression | ISO | SCRG1 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of SCRG1 mRNA | CTD | PMID:23806026 | silver atom | increases expression | ISO | Scrg1 (Mus musculus) | 6480464 | Silver results in increased expression of SCRG1 mRNA | CTD | PMID:27131904 | silver(0) | increases expression | ISO | Scrg1 (Mus musculus) | 6480464 | Silver results in increased expression of SCRG1 mRNA | CTD | PMID:27131904 | sodium arsenate | multiple interactions | ISO | SCRG1 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SCRG1 mRNA | CTD | PMID:32525701 | sunitinib | increases expression | ISO | SCRG1 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of SCRG1 mRNA | CTD | PMID:31533062 | temozolomide | increases expression | ISO | SCRG1 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of SCRG1 mRNA | CTD | PMID:31758290 | Tesaglitazar | decreases expression | EXP | | 6480464 | tesaglitazar results in decreased expression of SCRG1 mRNA | CTD | PMID:21515302 | testosterone enanthate | affects expression | ISO | SCRG1 (Homo sapiens) | 6480464 | testosterone enanthate affects the expression of SCRG1 mRNA | CTD | PMID:17440010 | Tributyltin oxide | increases expression | ISO | Scrg1 (Mus musculus) | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of SCRG1 mRNA | CTD | PMID:18958704 | trichloroethene | increases methylation | EXP | | 6480464 | Trichloroethylene results in increased methylation of SCRG1 gene | CTD | PMID:27618143 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of SCRG1 mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | SCRG1 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of SCRG1 mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | ISO | SCRG1 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCRG1 mRNA | CTD | PMID:27188386 | troglitazone | affects expression | EXP | | 6480464 | troglitazone affects the expression of SCRG1 mRNA | CTD | PMID:21515302 | valproic acid | decreases expression | ISO | SCRG1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of SCRG1 mRNA | CTD | PMID:23179753 | valproic acid | affects expression | ISO | SCRG1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SCRG1 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | SCRG1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SCRG1 mRNA | CTD | PMID:24383497 and PMID:26272509 | valproic acid | multiple interactions | ISO | SCRG1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCRG1 mRNA | CTD | PMID:27188386 | vorinostat | multiple interactions | ISO | SCRG1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCRG1 mRNA | CTD | PMID:27188386 | vorinostat | increases expression | ISO | SCRG1 (Homo sapiens) | 6480464 | vorinostat results in increased expression of SCRG1 mRNA | CTD | PMID:26272509 | |